Suppr超能文献

胰岛素(INS)和胰岛素样生长因子-I(IGF-I)在调节人类红细胞生成中的作用。无血清条件下的体外研究——与其他细胞因子和生长因子的比较。

The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis. Studies in vitro under serum-free conditions--comparison to other cytokines and growth factors.

作者信息

Ratajczak J, Zhang Q, Pertusini E, Wojczyk B S, Wasik M A, Ratajczak M Z

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.

出版信息

Leukemia. 1998 Mar;12(3):371-81. doi: 10.1038/sj.leu.2400927.

Abstract

The role of insulin (INS), and insulin-like growth factor-I (IGF-I) in the regulation of human erythropoiesis is not completely understood. To address this issue we employed several complementary strategies including: serum free cloning of CD34+ cells, RT-PCR, FACS analysis, and mRNA perturbation with oligodeoxynucleotides (ODN). In a serum-free culture model, both INS and IGF-I enhanced survival of CD34+ cells, but neither of these growth factors stimulated their proliferation. The influence of INS and IGF-I on erythroid colony development was dependent on a combination of growth factors used for stimulating BFU-E growth. When BFU-E growth was optimally stimulated with erythropoietin (EpO) + kit ligand (KL) the large erythroid colonies developed normally even in the absence of INS or IGF-I. However, the addition of both of these growth factors slightly enhanced colony size. On the other hand, if erythroid colonies were stimulated suboptimally with EpO + IL-3 only, INS or IGF-I increased the number of small erythroid bursts by approximately 30%. Both INS and IGF-I activated signal transduction in maturing human erythropoietic cells as determined by phosphorylation of the insulin receptor substrate-2 (IRS-2) protein. We also found by RT-PCR that mRNA coding for INS-R is expressed in FACS sorted CD34+, c-kit-R+ marrow cells, and in cells isolated from BFU-E and CFU-GM colonies. Expression of INS-R protein on these cells was subsequently confirmed by cytofluorometry. In contrast, the receptor for insulin-like growth factor-I (IGF-IR) was not detected on CD34+ cells, and was first easily detectable on more differentiated cells derived from day 6 BFU-E and CFU-GM colonies. We conclude that INS and IGF-I may be survival factors for human CD34+ cells, but are not required during early erythropoiesis. In contrast, both growth factors may play some role at the final stages of erythroid maturation.

摘要

胰岛素(INS)和胰岛素样生长因子-I(IGF-I)在人类红细胞生成调节中的作用尚未完全明确。为解决这一问题,我们采用了多种互补策略,包括:CD34+细胞的无血清克隆、逆转录聚合酶链反应(RT-PCR)、荧光激活细胞分选术(FACS)分析以及用寡脱氧核苷酸(ODN)干扰信使核糖核酸(mRNA)。在无血清培养模型中,INS和IGF-I均能提高CD34+细胞的存活率,但这两种生长因子均未刺激其增殖。INS和IGF-I对红系集落发育的影响取决于用于刺激爆式红系集落形成单位(BFU-E)生长的生长因子组合。当用促红细胞生成素(EpO)+干细胞因子(KL)最佳刺激BFU-E生长时,即使在没有INS或IGF-I的情况下,大型红系集落也能正常发育。然而,添加这两种生长因子会略微增加集落大小。另一方面,如果仅用EpO +白细胞介素-3(IL-3)对红系集落进行次优刺激,INS或IGF-I会使小红系爆式集落的数量增加约30%。如通过胰岛素受体底物-2(IRS-2)蛋白磷酸化所确定的,INS和IGF-I均可激活成熟人类造血细胞中的信号转导。我们还通过RT-PCR发现,编码胰岛素受体(INS-R)的mRNA在FACS分选的CD34+、c-kit受体(c-kit-R)+骨髓细胞以及从BFU-E和粒-巨噬细胞集落形成单位(CFU-GM)集落中分离的细胞中表达。随后通过细胞荧光测定法证实了这些细胞上INS-R蛋白的表达。相比之下,在CD34+细胞上未检测到胰岛素样生长因子-I受体(IGF-IR),在源自第6天BFU-E和CFU-GM集落的分化程度更高的细胞上首次易于检测到该受体。我们得出结论,INS和IGF-I可能是人类CD34+细胞的存活因子,但在早期红细胞生成过程中并非必需。相比之下,这两种生长因子可能在红系成熟的最后阶段发挥一定作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验